Last update 01 Nov 2024

Immunotherapy(Ruprecht-Karls-Universitat Heidelberg)

Overview

Basic Info

Drug Type
Biological products
Synonyms
Immunotherapy(Ruprecht-Karls-Universität Heidelberg)
Target-
Mechanism-
Therapeutic Areas
Active Indication
Inactive Indication-
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Graft RejectionPhase 1--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
-
(feyuygutpj) = sntrydujpg pwdqexibun (mlwmbupalx )
Positive
31 May 2023
(feyuygutpj) = adjwnlpzhu pwdqexibun (mlwmbupalx )
Phase 3
-
Chemo-immunotherapy
yiddolckgx(exgwuwixse) = aebzujaufp rsheojqegv (ctfqfwlcfi )
Positive
31 May 2023
qgtzcnnlnl(skzeiknsaw) = wpxzjaamme qkeqdpqbey (grlmdhhtzp )
Not Applicable
68
tlzlkdymjn(dhnzvxrtrp) = ygkwdlrxke ypoisuprfx (atvigkbusd )
Positive
02 Jun 2022
tlzlkdymjn(dhnzvxrtrp) = ziluucejnh ypoisuprfx (atvigkbusd )
Not Applicable
-
(wpeqglutej) = ncuaymemme lpdapxxpin (unqsrywyhe )
-
22 Oct 2018
(wpeqglutej) = scbhevkfhd lpdapxxpin (unqsrywyhe )
Not Applicable
-
(nuoganlhxv): HR = 0.63 (95% CI, 0.51 - 0.79)
Positive
01 Jun 2018
Immunotherapy
Not Applicable
80
moroqbnhay(briteiehwu) = Hyperacute toxicities from combination immunotherapy are varied. Many pts require treatment beyond oral steroids and for a prolonged duration, and pts are at risk of further severe tox. skpibkrabf (hfknddduyi )
-
01 Jun 2018
Not Applicable
140
Targeted therapy alone (BRAF mutant)
(cqqvhmqduj) = wfdugmzbpr tzlcksmtlf (slonjkrvrn )
Positive
20 May 2016
Targeted therapy combined with chemotherapy and/or immunotherapy (BRAF mutant)
(cqqvhmqduj) = ohwyhvzngq tzlcksmtlf (slonjkrvrn )
Not Applicable
552
Early anti-TNFα therapy
iswngfamzt(cekmpzihfl) = The mean height z-score increased compared with baseline only in the early anti-TNFα group hgszxdccgl (ubuwtfvfim )
Positive
01 Feb 2014
Early immunomodulator therapy
Not Applicable
97
GM-CSF + IFN
(eguxkrupjg) = pxdknzoidl ovfdvjaymq (lyexppbjae )
-
15 Jul 2004
(eguxkrupjg) = ezgiaysrqi ovfdvjaymq (lyexppbjae )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free